SFO
INGN icon

Stokes Family Office’s Inogen INGN Stock Holding History

Stokes Family Office’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-210,000
Closed -$1.41M – 298
2025
Q4 		$1.41M Sell
210,000
-12,622
-6% -$94.7K 0.13% 110
2025
Q3 		$1.82M Sell
222,622
-2,047
-0.9% -$15.3K 0.17% 100
2025
Q2 		$1.58M Buy
224,669
+16,945
+8% +$114K 0.17% 100
2025
Q1 		$1.48M Buy
207,724
+44,224
+27% +$417K 0.17% 102
2024
Q4 		$1.5M Buy
163,500
+36,715
+29% +$343K 0.16% 99
2024
Q3 		$1.23M Buy
126,785
+12,800
+11% +$134K 0.13% 107
2024
Q2 		$927K Buy
113,985
+70,500
+162% +$546K 0.11% 121
2024
Q1 		$351K Buy
+43,485
New +$308K 0.04% 174

Other funds holding INGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stokes Family Office's INGN Position: Q1 2026 in Review

Stokes Family Office sold out of Inogen (INGN) in Q1 2026, closing a stake of 210,000 shares — an estimated $1.41M sold.

Stokes Family Office first reported a position in INGN in Q1 2024 and held it in 8 quarters. The position peaked at $1.82M in Q3 2025. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • Stokes Family Office reported no remaining Inogen position as of Q1 2026 after selling out during the quarter.
  • Stokes Family Office sold 210,000 Inogen shares in Q1 2026, an estimated $1.41M.
  • Stokes Family Office first reported a position in Inogen in Q1 2024 and held it in 8 quarters.
  • Stokes Family Office's Inogen position peaked at $1.82M in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on Stokes Family Office's 13F filing for Q1 2026, filed 12 May 2026.